Elena Crisà

884 total citations
28 papers, 201 citations indexed

About

Elena Crisà is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Elena Crisà has authored 28 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 16 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Elena Crisà's work include Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Elena Crisà is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Elena Crisà collaborates with scholars based in Italy, United Kingdom and United States. Elena Crisà's co-authors include Dario Ferrero, Mario Boccadoro, Gianluca Gaïdano, Roberto Passera, Valentina Giai, Andrea Patriarca, Maura Nicolosi, Valentina Ferri, Chiara Favini and Wael Al Essa and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and British Journal of Haematology.

In The Last Decade

Elena Crisà

26 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Crisà Italy 7 142 111 76 38 21 28 201
Bernardine Favre France 8 129 0.9× 73 0.7× 72 0.9× 31 0.8× 16 0.8× 14 187
Elisabetta Colaci Italy 6 64 0.5× 59 0.5× 28 0.4× 23 0.6× 21 1.0× 11 112
Siris Patel India 11 230 1.6× 253 2.3× 26 0.3× 13 0.3× 11 0.5× 31 320
Montserrat Rafel Spain 5 184 1.3× 183 1.6× 99 1.3× 51 1.3× 59 2.8× 9 293
Marie Passet France 5 134 0.9× 68 0.6× 53 0.7× 12 0.3× 12 0.6× 8 210
Beatriz Cuevas Spain 7 87 0.6× 83 0.7× 59 0.8× 43 1.1× 9 0.4× 16 163
Yıldız Aydın Türkiye 8 74 0.5× 60 0.5× 13 0.2× 25 0.7× 28 1.3× 39 176
Cecelia Perkins United States 4 37 0.3× 49 0.4× 37 0.5× 74 1.9× 17 0.8× 11 157
Shelby A. Rogers United States 4 80 0.6× 67 0.6× 40 0.5× 9 0.2× 29 1.4× 8 163
Monica Maccaferri Italy 7 53 0.4× 76 0.7× 16 0.2× 31 0.8× 31 1.5× 17 160

Countries citing papers authored by Elena Crisà

Since Specialization
Citations

This map shows the geographic impact of Elena Crisà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Crisà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Crisà more than expected).

Fields of papers citing papers by Elena Crisà

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Crisà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Crisà. The network helps show where Elena Crisà may publish in the future.

Co-authorship network of co-authors of Elena Crisà

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Crisà. A scholar is included among the top collaborators of Elena Crisà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Crisà. Elena Crisà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crisà, Elena, Irene Dogliotti, Giuseppe Lia, et al.. (2025). Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm. Cancers. 17(17). 2874–2874.
2.
Lupia, Tommaso, Elena Crisà, Giacomo Stroffolini, et al.. (2024). Presumptive pulmonary toxocariasis in a patient affected by acute myeloid leukemia and Hodgkin lymphoma: case report and review of the literature in immunocompromised hosts. Infezioni in Medicina. 32(1). 103–112. 1 indexed citations
3.
Lupia, Tommaso, Fabrizio Carnevale‐Schianca, Alessandro Busca, et al.. (2024). Stenotrophomonas maltophilia Infections in Haematological Malignancies and Hematopoietic Stem Cell Transplantation: A Case Series including Cefiderocol-Based Regimens. Medicina. 60(1). 88–88. 6 indexed citations
4.
Lupia, Tommaso, Elena Crisà, Fabrizio Carnevale‐Schianca, et al.. (2023). Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature. Tropical Medicine and Infectious Disease. 8(7). 358–358. 3 indexed citations
5.
Lupia, Tommaso, Elena Crisà, Fabrizio Carnevale‐Schianca, et al.. (2023). Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma. Tropical Medicine and Infectious Disease. 8(6). 331–331. 1 indexed citations
6.
Crisà, Elena, Novella Pugliese, Andrea Castelli, et al.. (2022). Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia. European Journal Of Haematology. 110(4). 354–361. 1 indexed citations
7.
Nicolosi, Maura, Andrea Patriarca, Alessandra Gennari, et al.. (2021). Precision Medicine in Systemic Mastocytosis. Medicina. 57(11). 1135–1135. 6 indexed citations
8.
Lessi, Federica, Cristina Papayannidis, Francesco Grimaldi, et al.. (2021). Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study. Biomedicines. 9(8). 972–972. 2 indexed citations
9.
Crisà, Elena, Austin Kulasekararaj, Vera Ademà, et al.. (2020). Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7. Leukemia. 34(9). 2441–2450. 10 indexed citations
10.
Petiti, Jessica, Giovanna Rege‐Cambrin, Enrico Gottardi, et al.. (2020). Treatment-free remission in Chronic Myeloid Leukemia harboring atypical BCR-ABL1 transcripts.. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020066–e2020066. 6 indexed citations
11.
Rege‐Cambrin, Giovanna, Enrico Gottardi, Filomena Daraio, et al.. (2019). PS1179 TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS HARBORING ATYPICAL BCR‐ABL1 TRANSCRIPTS. HemaSphere. 3(S1). 536–537. 1 indexed citations
12.
Harrington, Patrick, Sophie Jackson, Aytug Kizilors, et al.. (2019). Clinical Intervention Using NGS-Based Kinase Domain Mutation Testing in CML Patients. Clinical Lymphoma Myeloma & Leukemia. 19. S293–S294. 2 indexed citations
13.
Brunello, Lucia, Roberto Passera, Chiara Maria Dellacasa, et al.. (2018). Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients. Annals of Hematology. 97(11). 2205–2215. 4 indexed citations
14.
Crisà, Elena, Daniela Cilloni, Elena Maria Elli, et al.. (2018). The use of erythropoiesis‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. British Journal of Haematology. 182(5). 701–704. 22 indexed citations
15.
Pugliese, Novella, Claudia Giordano, Luigia Luciano, et al.. (2018). Adding Hydroxyurea in Combination with Ruxolitinib Improves Clinical Responses in Hyperproliferative Forms of Myelofibrosis. Blood. 132(Supplement 1). 4290–4290. 1 indexed citations
16.
Ferrero, Dario, Elena Crisà, Filippo Marmont, et al.. (2014). Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. Annals of Hematology. 93(8). 1391–1400. 20 indexed citations
17.
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernardine Favre Breakdown of academic impact, for papers by Elisabetta Colaci Breakdown of academic impact, for papers by Siris Patel Breakdown of academic impact, for papers by Montserrat Rafel Breakdown of academic impact, for papers by Marie Passet Breakdown of academic impact, for papers by Beatriz Cuevas Breakdown of academic impact, for papers by Yıldız Aydın Breakdown of academic impact, for papers by Cecelia Perkins Breakdown of academic impact, for papers by Shelby A. Rogers Breakdown of academic impact, for papers by Monica Maccaferri
Rankless by CCL
2026